Immunomedics(IMMU)

群氓鄙陋2018-05-16 10:10

$$Zymeworks Inc.(ZYME)$ $Mersana Therapeutics, Inc.(MRSN)$ $Immunomedics, Inc. (IMMU)$ 乳腺癌药物美股标的Mark！谢谢楼主的无私分享查看全文

淘沙见金2018-05-15 12:06

$$Zymeworks Inc.(ZYME)$ $Mersana Therapeutics, Inc.(MRSN)$ $Immunomedics, Inc. (IMMU)$ 今年ASCO乳腺癌重点关注的几家。其中ZYME的HER2靶向双特异性抗体和MRSN的XMT-1522是重点关注的对象。查看全文

祷告是最大资产2018-05-01 13:56

$Immunomedics, Inc. (IMMU)$ 这么大涨幅，没有看到消息，非常奇怪查看全文

祷告是最大资产2018-04-10 08:37

$Immunomedics, Inc. (IMMU)$ new chief with az background joined, helpful for combo. great action. behzad really ambitious. ceo do the right thing. go go go查看全文

祷告是最大资产2018-04-03 08:43

$Immunomedics, Inc. (IMMU)$ Someone at the meeting told me that management is going to focus on three indications (for now) for 132, TNBC, UT and erMBC.
They are confident that the BLA will be filed in late May, and they continue to work towards commercial launch this ye...查看全文

祷告是最大资产2018-03-16 12:20

$Immunomedics, Inc. (IMMU)$ 转 I don't remember if the board has ever discussed potential revenues(why on earth would we?), but with the imminent BLA, I thought I'd run a few numbers. First, what will a course of treatment of 132 cost? The 3 currently approved ADCs ru...查看全文

祷告是最大资产2018-03-14 22:55

$Immunomedics, Inc. (IMMU)$ 2018q1表现真的有些弱。查看全文

祷告是最大资产2018-03-07 09:35

$Immunomedics, Inc. (IMMU)$ 今天，做一个有意思的分析和推算。（不做投资参考）
 
我们来看一下当前生物医药公司估值的评判。
以成熟生物制药公司Celgene为例，核心肿瘤产品，来那度胺年销售80亿美元，公司市值700亿美元。再以Seattle为例，核心产品Adcetris年销售额6亿美元，市值8...查看全文

Pharmayang2018-03-02 12:35

$Immunomedics, Inc. (IMMU)$ 纯讨论，这是irrinotican(SN38)的ADC，所以efficacy基本已经定了，主要是减轻irrinotican的副作用。现在TNBC给了breakthrough designation, peak sales在500million，现在的market已经2.6B，这个indication已经price in。要看其他indication的情况，短期貌似上涨的空...查看全文

祷告是最大资产2018-02-28 22:58

$Immunomedics, Inc. (IMMU)$ 最近immu好平静。看来，新CEO需要安心做P3,以及AA申请，还有多个适应症的临床实验。祝132成功，成为最棒的ADC查看全文

云顶新耀-B(01952)与吉利德附属订立终止及过渡服务协议 总代价最高约4.55亿美元

智通财经APP讯，云顶新耀-B(01952)发布公告，于2022年8月15日，公司、Everest Medicines II及Everest SG(各自为公司的全资附属公司)与Immunomedics(吉利德的全资附属公司)订立终止及过渡服务协议，各订约方已有条件同意完成交易，总代价... 网页链接

$Immunomedics(IMMU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-20-117808  Act: 33  Size: 37 KB 网页链接

$Immunomedics(IMMU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-20-117809  Act: 33  Size: 37 KB 网页链接

$Immunomedics(IMMU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-20-117872  Act: 33  Size: 37 KB 网页链接

$Immunomedics(IMMU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-20-117876  Act: 33  Size: 37 KB 网页链接

$Immunomedics(IMMU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-20-117810  Act: 33  Size: 37 KB 网页链接

$Immunomedics(IMMU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-20-117811  Act: 33  Size: 37 KB 网页链接

$Immunomedics(IMMU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-20-117812  Act: 33  Size: 37 KB 网页链接

$Immunomedics(IMMU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-20-117815  Act: 33  Size: 37 KB 网页链接

$Immunomedics(IMMU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-117803  Size: 11 KB 网页链接

$Immunomedics(IMMU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-117805  Size: 8 KB 网页链接